Brain Health and Cognitive Health

FDA Approves Lilly’s Kisunla for Early Symptomatic Alzheimer’s Disease

Eli Lilly’s Kisunla (donanemab-azbt) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of early symptomatic Alzheimer’s disease. This includes adults with mild cognitive impairment (MCI) and mild dementia stages of the disease. Alzheimer’s disease affects women disproportionately, with nearly two-thirds of Americans diagnosed being women. The pivotal Phase 3 study, TRAILBLAZER-ALZ 2, showed that Kisunla slowed…

Neuromodulation and Women’s Health

Image: Myoovi You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.

Octave Bioscience Secures $30M for Its Precision Care Solution for Multiple Sclerosis

Autoimmune disease happens when the body’s natural defense system can’t tell the difference between own cells and foreign cells, causing the body to attack normal cells mistakenly. One of the most common autoimmune diseases is multiple sclerosis (in short MS), a potentially disabling disease of the central nervous system. In MS, the immune system attacks the protective sheath that covers nerve fibers and causes communication…

Researchers Secure £1.5M for Their ‘Fastball’ Test to Detect Alzheimer’s Earlier

Dementia describes a set of symptoms that over time can affect memory, problem-solving, language and behaviour. Alzheimer’s disease is the most common type of dementia. On a global level women with dementia outnumber men 2 to 1. Brain scans have shown that brain cells are dying faster in the women’s than men’s brains. Researchers at the universities of Bath and Bristol, in…

Female-led Virtual Neurology Clinic Neura Health Adds $8M in Seed Funding

Virtual neurology clinic Neura Health has raised $8M in seed funding to expand its go-to-market approach and bring its neurology care offerings to the enterprise sector. The funding round was led by Koch Disruptive Technologies and Norwest Venture Partners, with participation from Pear VC, Next Play Ventures, Correlation Ventures, and Plug and Play Ventures. This latest financing round builds upon Neura’s $2.M…

Hopelab Invests $1.5M in Five Startups Who Are Redefining Mental Health Care for LGBTQ+ and BIPOC Youth

Hopelab, a leading social innovation lab and impact investor helping advance a new generation of mental health entrepreneurs has made investments into Brave Health, Caraway Health, InStride, MindRight Health and violet. With these latest additions to its portfolio, Hopelab provides $1.5M in funding to help diversify care in the youth mental health space and improve the well-being of BIPOC and LGBTQ+ young people. “Today’s young people experience compounding…

Dementia DTx Startup Five Lives Raises €3.7M to Fund Clinical Validation and Growth

Dementia describes a set of symptoms that over time can affect memory, problem-solving, language and behaviour. Alzheimer’s disease is the most common type of dementia. On a global level women with dementia outnumber men 2 to 1. Brain scans have shown that brain cells are dying faster in the women’s than men’s brains. Founded in 2019 Five Lives, a UK- and France-based…

New Book: Women’s Brain Project Releases “Sex and Gender Bias in Technology and Artificial Intelligence: Biomedicine and Healthcare Applications”

Non-profit organization The Women’s Brain Project has published its newest book, “Sex and Gender Bias in Technology and Artificial Intelligence: Biomedicine and Healthcare Applications” in collaboration with Elsevier and a group of international experts and initiatives including the Bioinfo4Women program at Barcelona Supercomputing Center. Women’s Brain Project Co-founder & CEO Dr. Antonella Santuccione Chadha shares: “This textbook was much needed because it collects for the very first…